Analysis of the mechanism of antibody-dependent enhancement of feline infectious peritonitis virus infection: aminopeptidase N is not important and a process of acidification of the endosome is necessary

References

1. Addie D. D., Toth S., Murray G. D., Jarrett O. 1995; Risk of feline infectious peritonitis in cats naturally infected with feline coronavirus. Am J Vet Res 56:429–434
   [Google Scholar]
2. Corapi W. V., Olsen C. W., Scott F. W. 1992; Monoclonal antibody analysis of neutralization and antibody-dependent enhancement of feline infectious peritonitis virus. J Virol 66:6695–6705
   [Google Scholar]
3. Dewerchin H. L., Cornelissen E., Nauwynck H. J. 2005; Replication of feline coronaviruses in peripheral blood monocytes. Arch Virol 150:2483–2500 [CrossRef]
   [Google Scholar]
4. Gollins S. W., Porterfield J. S. 1986; A new mechanism for the neutralization of enveloped viruses by antiviral antibody. Nature 321:244–246 [CrossRef]
   [Google Scholar]
5. Halstead S. B. 2003; Neutralization and antibody-dependent enhancement of dengue viruses. Adv Virus Res 60:421–467
   [Google Scholar]
6. Hohdatsu T., Okada S., Koyama H. 1991a; Characterization of monoclonal antibodies against feline infectious peritonitis virus type II and antigenic relationship between feline, porcine, and canine coronaviruses. Arch Virol 117:85–95 [CrossRef]
   [Google Scholar]
7. Hohdatsu T., Nakamura M., Ishizuka Y., Yamada H., Koyama H. 1991b; A study on the mechanism of antibody-dependent enhancement of feline infectious peritonitis virus infection in feline macrophages by monoclonal antibodies. Arch Virol 120:207–217 [CrossRef]
   [Google Scholar]
8. Hohdatsu T., Yamada H., Ishizuka Y., Koyama H. 1993; Enhancement and neutralization of feline infectious peritonitis virus infection in feline macrophages by neutralizing monoclonal antibodies recognizing different epitopes. Microbiol Immunol 37:499–504 [CrossRef]
   [Google Scholar]
9. Hohdatsu T., Izumiya Y., Yokoyama Y., Kida K., Koyama H. 1998; Differences in virus receptor for type I and type II feline infectious peritonitis virus. Arch Virol 143:839–850 [CrossRef]
   [Google Scholar]
10. Mason P. W., Rieder E., Baxt B. 1994; RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway. Proc Natl Acad Sci U S A 91:1932–1936 [CrossRef]
    [Google Scholar]
11. Motokawa K., Hohdatsu T., Aizawa C., Koyama H., Hashimoto H. 1995; Molecular cloning and sequence determination of the peplomer protein gene of feline infectious peritonitis virus type I. Arch Virol 140:469–480 [CrossRef]
    [Google Scholar]
12. Motokawa K., Hohdatsu T., Hashimoto H., Koyama H. 1996; Comparison of the amino acid sequence and phylogenetic analysis of the peplomer, integral membrane and nucleocapsid proteins of feline, canine and porcine coronaviruses. Microbiol Immunol 40:425–433 [CrossRef]
    [Google Scholar]
13. Olsen C. W. 1993; A review of feline infectious peritonitis virus: molecular biology, immunopathogenesis, clinical aspects, and vaccination. Vet Microbiol 36:1–37 [CrossRef]
    [Google Scholar]
14. Olsen C. W., Corapi W. V., Ngichabe C. K., Baines J. D., Scott F. W. 1992; Monoclonal antibodies to the spike protein of feline infectious peritonitis virus mediate antibody-dependent enhancement of infection of feline macrophages. J Virol 66:956–965
    [Google Scholar]
15. Qiu Z., Hingley S. T., Simmons G., Yu C., Das Sarma J., Bates P., Weiss S. R. 2006; Endosomal proteolysis by cathepsins is necessary for murine coronavirus mouse hepatitis virus type 2 spike-mediated entry. J Virol 80:5768–5776 [CrossRef]
    [Google Scholar]
16. Rottier P. J., Nakamura K., Schellen P., Volders H., Haijema B. J. 2005; Acquisition of macrophage tropism during the pathogenesis of feline infectious peritonitis is determined by mutations in the feline coronavirus spike protein. J Virol 79:14122–14130 [CrossRef]
    [Google Scholar]
17. Simmons G., Gosalia D. N., Rennekamp A. J., Reeves J. D., Diamond S. L., Bates P. 2005; Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc Natl Acad Sci U S A 102:11876–11881 [CrossRef]
    [Google Scholar]
18. Sullivan N. J. 2001; Antibody-mediated enhancement of viral disease. Curr Top Microbiol Immunol 260:145–169
    [Google Scholar]
19. Takano T., Hohdatsu T., Toda A., Tanabe M., Koyama H. 2007; TNF- α , produced by feline infectious peritonitis virus (FIPV)-induced macrophages, upregulates expression of type II FIPV receptor feline aminopeptidase N in feline macrophages. Virology 364:64–72 [CrossRef]
    [Google Scholar]
20. Takeda A., Sweet R. W., Ennis F. A. 1990; Two receptors are required for antibody-dependent enhancement of human immunodeficiency virus type 1 infection: CD4 and Fc γ R. J Virol 64:5605–5610
    [Google Scholar]
21. Tirado S. M., Yoon K. J. 2003; Antibody-dependent enhancement of virus infection and disease. Viral Immunol 16:69–86 [CrossRef]
    [Google Scholar]
22. Van Hamme E., Dewerchin H. L., Cornelissen E., Nauwynck H. J. 2007; Attachment and internalization of feline infectious peritonitis virus in feline blood monocytes and Crandell feline kidney cells. J Gen Virol 88:2527–2532 [CrossRef]
    [Google Scholar]